- Home
- SLGL vs HYFT Comparison
SLGL vs HYFT Comparison
Compare SLGL & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLGL | HYFT |
|---|---|---|
| Founded | 1997 | 1983 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 80.8M |
| IPO Year | 2018 | 2017 |
Fundamental Metrics
Financial Performance| Metric | SLGL | HYFT |
|---|---|---|
| Price | $41.96 | $2.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $50.00 | N/A |
| AVG Volume (30 Days) | 18.6K | ★ 378.9K |
| Earning Date | 11-20-2025 | 12-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $18,970,000.00 | $18,214,531.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $71.78 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 62.04 | 18.33 |
| 52 Week Low | $4.02 | $0.27 |
| 52 Week High | $52.26 | $3.25 |
Technical Indicators
Market Signals| Indicator | SLGL | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 66.91 | N/A |
| Support Level | $38.13 | N/A |
| Resistance Level | $37.95 | N/A |
| Average True Range (ATR) | 3.88 | 0.00 |
| MACD | 0.86 | 0.00 |
| Stochastic Oscillator | 85.01 | 0.00 |
Price Performance
Historical ComparisonAbout SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About HYFT MindWalk Holdings Corp. Common Stock
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.